+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Antacid Market Report and Forecast 2025-2034 - Product Thumbnail Image

Antacid Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Botox Market Report and Forecast 2025-2034 - Product Thumbnail Image

Botox Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Hemostasis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Hemostasis Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Ischemic Stroke Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Ischemic Stroke Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Hepatitis D Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Hepatitis D Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Alzheimer's Treatment Market Report and Forecast 2025-2034 - Product Thumbnail Image

Alzheimer's Treatment Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Schizophrenia Market Report and Forecast 2025-2034 - Product Thumbnail Image

Schizophrenia Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more